Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 45 (representing 25 labs)

Tests names and labsConditionsGenes and analytesMethods

Dihydropyrimidine dehydrogenase deficiency

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

DPYD. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

DPYD. Detection of the mutation IVS14 1G>A by sequencing

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

DPYD*13

Oncopharmacology and Pharmacogenetics Laboratory Institut de Cancerologie de l'Ouest - Centre Paul Papin
France
51
  • E Sequence analysis of select exons

DPYD*7

Oncopharmacology and Pharmacogenetics Laboratory Institut de Cancerologie de l'Ouest - Centre Paul Papin
France
51
  • E Sequence analysis of select exons

DPYD - D949V

Oncopharmacology and Pharmacogenetics Laboratory Institut de Cancerologie de l'Ouest - Centre Paul Papin
France
51
  • E Sequence analysis of select exons

DPD enzyme activity

Oncopharmacology and Pharmacogenetics Laboratory Institut de Cancerologie de l'Ouest - Centre Paul Papin
France
52
  • A Analyte

DPYD*2A

Oncopharmacology and Pharmacogenetics Laboratory Institut de Cancerologie de l'Ouest - Centre Paul Papin
France
51
  • E Sequence analysis of select exons

Dihydropyrimidine Dehydrogenase Deficiency via the DPYD Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Purine and Pyrimidine Panel - Urine

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
913
  • A Analyte

Pyrimidine Panel - Urine

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
35
  • A Analyte

nucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

5-FLUOROURACIL TOXICITY

Laboratorio de Genetica Clinica SL
Spain
11
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

DPD 5-Fluorouracil Toxicity

Molecular Diagnostic Laboratory LabCorp
United States
11
  • T Targeted variant analysis

Susceptibility to Drugs (5-Fluoruracil), Deletions-Duplications (MLPA) DPYD Gene

Reference Laboratory Genetics
Spain
11
  • D Deletion/duplication analysis

Susceptibility to Drugs (5-Fluoruracil) , Sequencing DPYD Gene and Genotype (2R/2R,2R/3R,3R/3R) TYMS Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

GeneAware Complete Panel Version 2 (Male)

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
164149
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

GeneAware Complete Panel Version 2 (Female)

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
175159
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Treatable Seizures Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
7251
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Family Prep Screen

Counsyl
United States
112110
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 45

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center